{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T04:09:39Z","timestamp":1780632579501,"version":"3.54.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001030","name":"National Heart Foundation of Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005859","name":"Heart Rhythm Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005859","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001316","name":"Abbott Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007497","name":"Biosense Webster","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007497","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Clinical Electrophysiology"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.jacep.2019.12.003","type":"journal-article","created":{"date-parts":[[2020,2,26]],"date-time":"2020-02-26T14:07:20Z","timestamp":1582726040000},"page":"484-490","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Direct Thrombin Inhibitors as an Alternative to Heparin During Catheter\u00a0Ablation"],"prefix":"10.1016","volume":"6","author":[{"given":"Aleksandr","family":"Voskoboinik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Butcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amneet","family":"Sandhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duy T.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Tzou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico G.","family":"Della Rocca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Natale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica S.","family":"Zado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis E.","family":"Marchlinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Aguilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Sauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usha B.","family":"Tedrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward P.","family":"Gerstenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacep.2019.12.003_bib1","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/jth.14372","article-title":"Imminent risk of a global shortage of heparin caused by the African swine fever afflicting the Chinese pig herd","volume":"17","author":"Vilanova","year":"2019","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jacep.2019.12.003_bib2","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1592\/phco.30.9.952","article-title":"Bivalirudin use during radiofrequency catheter ablation procedures in two patients with a history of heparin-induced thrombocytopenia","volume":"30","author":"Baetz","year":"2010","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jacep.2019.12.003_bib3","first-page":"367","article-title":"Successful ventricular tachycardia ablation in a patient with a biventricular ventricular assist device and heparin-induced thrombocytopenia using bivalirudin","volume":"4","author":"Ho","year":"2018","journal-title":"Heart Rhythm Case Rep"},{"key":"10.1016\/j.jacep.2019.12.003_bib4","first-page":"154","article-title":"Successful intraprocedural anticoagulation with bivalirudin during pulmonary vein isolation in a patient with known heparin-induced thrombocytopenia type II","volume":"32","author":"Bellmann","year":"2016","journal-title":"J\u00a0Arrhythm"},{"key":"10.1016\/j.jacep.2019.12.003_bib5","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/europace\/eux274","article-title":"2017 HRS\/EHRA\/ECAS\/APHRS\/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation","volume":"20","author":"Calkins","year":"2018","journal-title":"Europace"},{"key":"10.1016\/j.jacep.2019.12.003_bib7","author":"Bivalirudin"},{"key":"10.1016\/j.jacep.2019.12.003_bib8","first-page":"yty166","article-title":"A\u00a0case report of atrial fibrillation in a patient with heparin resistance associated with an antithrombin III deficiency successfully treated by radiofrequency catheter ablation using a direct thrombin inhibitor","volume":"3","author":"Kang","year":"2019","journal-title":"Eur Heart J Case Rep"},{"key":"10.1016\/j.jacep.2019.12.003_bib9","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/jce.12404","article-title":"Improving safety in catheter ablation for atrial fibrillation: a prospective study of the use of ultrasound to guide vascular access","volume":"25","author":"Wynn","year":"2014","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacep.2019.12.003_bib10","first-page":"82","article-title":"Impact of contact force technology on reducing the recurrence and major complications of atrial fibrillation ablation: a systematic review and meta-analysis","volume":"17","author":"Zhou","year":"2017","journal-title":"Anatol J Cardiol"},{"key":"10.1016\/j.jacep.2019.12.003_bib11","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1056\/NEJMra044440","article-title":"Direct thrombin inhibitors","volume":"353","author":"Di Nisio","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacep.2019.12.003_bib12","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1056\/NEJMoa0708191","article-title":"Bivalirudin during primary PCI in acute myocardial infarction","volume":"358","author":"Stone","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacep.2019.12.003_bib13","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1056\/NEJMoa1507854","article-title":"Bivalirudin or unfractionated heparin in acute coronary syndromes","volume":"373","author":"Valgimigli","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacep.2019.12.003_bib14","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.21037\/jtd.2018.05.76","article-title":"Bivalirudin versus heparin in percutaneous coronary intervention\u2014a systematic review and meta-analysis of randomized trials stratified by adjunctive glycoprotein IIb\/IIIa strategy","volume":"10","author":"Anantha-Narayanan","year":"2018","journal-title":"J\u00a0Thorac Dis"},{"key":"10.1016\/j.jacep.2019.12.003_bib15","first-page":"700","article-title":"Changing outcomes and treatment strategies for wire induced coronary perforations in the era of bivalirudin use","volume":"74","author":"Kini","year":"2009","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jacep.2019.12.003_bib16","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.jcin.2010.05.013","article-title":"Retroperitoneal hematoma after percutaneous coronary intervention: prevalence, risk factors, management, outcomes, and predictors of mortality: a report from the BMC2 (Blue Cross Blue Shield of Michigan Cardiovascular Consortium) registry","volume":"3","author":"Trimarchi","year":"2010","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacep.2019.12.003_bib17","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2174\/1874192401307010016","article-title":"Retroperitoneal hemorrhage as a complication of percutaneous intervention: report of 2 cases and review of the literature","volume":"7","author":"Sajnani","year":"2013","journal-title":"Open Cardiovasc Med J"},{"key":"10.1016\/j.jacep.2019.12.003_bib18","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/hrt.63.1.18","article-title":"Monitoring the effect of heparin by measurement of activated clotting time during and after percutaneous transluminal coronary angioplasty","volume":"63","author":"Rath","year":"1990","journal-title":"Br Heart J"},{"key":"10.1016\/j.jacep.2019.12.003_bib19","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/0735-1097(94)90590-8","article-title":"Relation between procedural activated coagulation time and outcome after percutaneous transluminal coronary angioplasty","volume":"23","author":"Ferguson","year":"1994","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2019.12.003_bib20","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1067\/mhj.2001.119374","article-title":"Bivalirudin versus heparin during coronary angioplasty for unstable or postinfarction angina: final report reanalysis of the Bivalirudin Angioplasty Study","volume":"142","author":"Bittl","year":"2001","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacep.2019.12.003_bib21","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1001\/jama.292.6.696","article-title":"Long-term efficacy of bivalirudin and provisional glycoprotein IIb\/IIIa blockade vs heparin and planned glycoprotein IIb\/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial","volume":"292","author":"Lincoff","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jacep.2019.12.003_bib22","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1056\/NEJMoa062437","article-title":"Bivalirudin for patients with acute coronary syndromes","volume":"355","author":"Stone","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacep.2019.12.003_bib23","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.amjcard.2004.05.068","article-title":"Value of monitoring activated clotting time when bivalirudin is used as the sole anticoagulation agent for percutaneous coronary intervention","volume":"94","author":"Cheneau","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacep.2019.12.003_bib24","first-page":"250","article-title":"Evaluation of bivalirudin hyper- and hypo-ACT responses in the setting of percutaneous coronary intervention","volume":"25","author":"Weeks","year":"2013","journal-title":"J\u00a0Invasive Cardiol"},{"key":"10.1016\/j.jacep.2019.12.003_bib25","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1213\/01.ane.0000205746.50440.98","article-title":"Measurement of patients' bivalirudin plasma levels by a thrombelastograph ecarin clotting time assay: a comparison to a standard activated clotting time","volume":"102","author":"Carroll","year":"2006","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jacep.2019.12.003_bib26","first-page":"131","article-title":"Update on argatroban for the prophylaxis and treatment of heparin-induced thrombocytopenia type II","volume":"5","author":"Grouzi","year":"2014","journal-title":"J\u00a0Blood Med"},{"key":"10.1016\/j.jacep.2019.12.003_bib27","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1056\/NEJMoa1701005","article-title":"Uninterrupted dabigatran versus warfarin for ablation in atrial fibrillation","volume":"376","author":"Calkins","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacep.2019.12.003_bib28","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1161\/CIRCEP.113.000768","article-title":"Complications of catheter ablation of atrial fibrillation: a systematic review","volume":"6","author":"Gupta","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"}],"container-title":["JACC: Clinical Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X19309569?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X19309569?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T07:27:26Z","timestamp":1762500446000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405500X19309569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S2405500X19309569"],"URL":"https:\/\/doi.org\/10.1016\/j.jacep.2019.12.003","relation":{},"ISSN":["2405-500X"],"issn-type":[{"value":"2405-500X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Direct Thrombin Inhibitors as an Alternative to Heparin During Catheter\u00a0Ablation","name":"articletitle","label":"Article Title"},{"value":"JACC: Clinical Electrophysiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacep.2019.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}